The Dutch question: should customs detain generics in transit?
This article was originally published in Scrip
The detention of generic drug shipments by the Dutch customs authorities has caused something of a furore, and one that seems likely to rage for some time. A solution is urgently needed, but the problem is that no-one – including the Dutch government itself - seems to know exactly what is going on.
You may also be interested in...
A “powerful new vision” for the post-Brexit UK regulatory framework was unveiled at a conference organized by the BioIndustry Association and the medicines regulator, the MHRA.
InflaRx and Relief Therapeutics/NeuroRx are investigating potential new treatments for COVID-19-induced pneumonia and for coronavirus-related ARDS.
The UK government has also entered into a supply deal with French firm Valneva for 60 million doses of its inactivated COVID-19 vaccine, VLA2001.